Laboratorio Reig Jofre SA Share Price CINNOBER BOAT
Stocks
0RB1
ES0165359029
Pharmaceuticals
| Market Cap | 219M 0 250M 202M 189M 354M 23.56B 362M 2.43B 939M 11.64B 938M 917M 40.38B | P/E 2026 * |
13.5x | P/E 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 304M 0 346M 280M 262M 491M 32.67B 502M 3.36B 1.3B 16.15B 1.3B 1.27B 55.99B | EV / Sales 2026 * |
0.83x | EV / Sales 2027 * | 0.76x |
| Free-Float |
19.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Laboratorio Reig Jofre SA
| 1 day | +2.41% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 31/12/2005 | |
Laura Martí
DFI | Director of Finance/CFO | - | 19/12/2023 |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/12/2014 | |
| Director/Board Member | 58 | 30/12/2014 | |
| Director/Board Member | - | 06/11/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.41% | -.--% | - | - | 250M | ||
| +7.13% | +9.97% | +55.80% | +160.09% | 1,077B | ||
| +3.99% | +11.50% | +67.09% | +55.96% | 613B | ||
| +4.20% | +17.03% | +38.97% | +91.06% | 448B | ||
| +0.99% | +4.85% | +28.17% | +23.89% | 332B | ||
| +1.82% | +8.19% | +40.04% | +27.95% | 293B | ||
| +0.22% | +6.75% | +31.30% | +42.34% | 286B | ||
| +0.73% | +8.53% | -27.33% | -39.55% | 215B | ||
| +1.56% | +6.14% | +29.30% | +60.97% | 193B | ||
| +3.26% | +3.33% | +15.55% | +68.24% | 159B | ||
| Average | +2.63% | +8.00% | +30.99% | +54.55% | 401.79B | |
| Weighted average by Cap. | +3.85% | +8.93% | +41.75% | +80.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 365M 0 416M 336M 315M 590M 39.26B 603M 4.04B 1.56B 19.4B 1.56B 1.53B 67.28B | 392M 0 447M 361M 338M 634M 42.16B 647M 4.34B 1.68B 20.84B 1.68B 1.64B 72.26B |
| Net income | 16.7M 0 19.05M 15.39M 14.41M 27.02M 1.8B 27.59M 185M 71.59M 888M 71.52M 69.96M 3.08B | 9.5M 0 10.83M 8.76M 8.2M 15.37M 1.02B 15.69M 105M 40.73M 505M 40.68M 39.8M 1.75B |
| Net Debt | 84.7M 0 96.6M 78.07M 73.09M 137M 9.11B 140M 938M 363M 4.5B 363M 355M 15.62B | 78.7M 0 89.76M 72.54M 67.92M 127M 8.47B 130M 872M 337M 4.18B 337M 330M 14.51B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















